by Jessica Casebolt | Jul 16, 2024 | Access & Coverage, Tea Leaves
The Supreme Court dismissed a significant abortion case on Thursday, marking a temporary win for abortion-rights advocates in Idaho. The case involved the state’s near-total ban on abortion, which permits emergency abortions only to save a pregnant...
by Jessica Casebolt | Jul 16, 2024 | Opioid/Substance Use Disorders, Tea Leaves
Arkansas Attorney General Tim Griffin revealed the state is filing a lawsuit against pharmacy benefit managers (PBMs) Optum and Express Scripts for their role in the state’s ongoing opioid epidemic. In the lawsuit, the state argues the PBMs negotiated deals with...
by Jessica Casebolt | Jul 16, 2024 | M&A, Tea Leaves
A recent National Bureau of Economic Research working paper reveals that increased health care costs following hospital mergers lead to higher insurance premiums for employers, prompting them to lay off employees rather than reduce wages. Researchers from multiple...
by Jessica Casebolt | Jul 16, 2024 | Life Sciences, Tea Leaves
Early research suggests a new slow-release ketamine pill could offer a promising option for treating hard-to-treat depression with fewer side effects compared to existing treatments. While no form of ketamine has FDA approval for psychiatric disorders, derivatives...
by Jessica Casebolt | Jul 16, 2024 | Health IT, Tea Leaves
The health care industry has received a commendable “B+” grade in cybersecurity from SecurityScorecard, indicating stronger security practices than anticipated. The assessment focused on the top 500 health care companies, predominantly pharmaceutical and...
Recent Comments